SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2827I'll go on record, I predict a Novartis munch within 12 months. Cash+CVR'rkrw-9/19/2011
2826The FDA webpage for generic Lovenox now has an updated “Q&A” at fda.gov thaDewDiligence_on_SI-9/19/2011
2825The interpretation of the Amphastar news leaves a few pages glued together (see tom pope-9/19/2011
2824It is just remarkable how the slimmest of speculations causes huge moves in MNTAsemi_infinite -9/19/2011
2823cs: Teva Pharmaceutical Industries (TEVA) RESTRICTED M. Faerm CP: US$ 38.33 TP: mopgcw-9/17/2011
2822I wouldn't begin to try to decipher the case! But perhaps others will chime rkrw-9/17/2011
2821New stuff from the docket provides a little more color on the competing processetuck-9/2/2011
2820See siliconinvestor.com . Regards, Dew p.s. Updated <i>ReadMeFirst&DewDiligence_on_SI-8/29/2011
2819And on this news, MNTA closed up $0.93! 11:39AM Teva Pharma; court adopts all rIan@SI-8/29/2011
2818I wonder if Big Pharma/Biotech are clients of Decision Resources..... Biosimilarkrw-8/10/2011
2817Momenta Pharmaceuticals Second Quarter 2011 - Earnings Call Transcript Earninmopgcw-8/6/2011
2816Certainly didn't seem to help the stock price. Perhaps the institutionalIan@SI-8/5/2011
2815One bit of good new news is that the royalty rate in the event of a second genertuck-8/5/2011
2814merchantgould.com analysis of the legal and legislative aspects of the biosimilsoftware salesperson-8/4/2011
2813I guess we should be grateful for this morning's earnings report. MNTA onlyIan@SI18/4/2011
2812FDA: Generic biotech drugs require paradigm shift * FDA givesmopgcw-8/3/2011
2811I don't know all of what SI's people have posted to you, Dew, but after Jeffry K. Smith47/28/2011
2810Are you saying Roy is a Pokémon ? My son helped me find the right one: [gidos27/28/2011
2809You have bad breath and are bow legged.rkrw37/28/2011
2808<i>>Teva's [Lovenox] approval is likely, no matter what some say, bDewDiligence_on_SI-7/27/2011
2807The analysts should have stayed at the trial longer than two days, according to DewDiligence_on_SI-7/27/2011
2806WSJ: Threat of Generic Copycat Comes Back to Nip at Teva By JONATHAN D. ROCKOFFmopgcw17/24/2011
2805Leerink: MNTA – OP – Joseph P. Schwartz Close: $19.92, Mkt Cap: $1,013M ·IRWIN JAMES FRANKEL37/12/2011
2804Bring the toxicology experts on :)idos-7/12/2011
2803>>to the unexpected discoveries of a positive MW-toxicity correlation and IRWIN JAMES FRANKEL-7/12/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News